zur Navigation zum Inhalt
Onkologie 9. April 2012

Continuous treatment with lenalidomide in multiple myeloma: a case report

We present the case of a 72-year-old woman diagnosed with multiple myeloma (MM) in 1992 and treated with lenalidomide plus dexamethasone (LD) as third-line therapy. The patient achieved a complete remission (CR) after 6 cycles of LD treatment, was treated with LD for almost 4 years, and has now been in CR for 5 years. This case illustrates the potential of lenalidomide for continuous treatment in MM, with side effects controllable through tailored patient management including step-wise dose adaptations.

E. Müldür, A. Weißmann, C. Leitgeb, N. Zojer, M. Schreder, D. Heintel, H. Ludwig, memo - Magazine of European Medical Oncology 1/2012

Volltext dieses Beitrags / entire article auf SpringerLink

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben